Novel Alzheimer’s drug passes first phase of human testing

A new drug for treating Alzheimer’s disease has successfully passed the first phase of testing in humans. Preclinical studies had already shown that the drug could improve memory and other symptoms of Alzheimer’s disease in older mice. Researchers at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf, both in Germany, developed the candidate drug, which, for…

Read More

New drug promises to lower risks of asthma attack

A recent study shows that a gamechanger drug called Fevipiprant promises to lower patients’ risks of suffering an asthma attack and being admitted to a hospital. This is the first time a drug reducing airway smooth muscle mass—a key clinical indicator of disease severity that increases the likelihood of more frequent asthma attacks and even deaths—has been reported. Along with Rod…

Read More